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Objective: To establish reliability and validity of real-time ﬂuorescent PCR for early detection of bacterial
invasion of the amniotic cavity.
Methods: Amniotic ﬂuid samples from 40 patients undergoing mid-trimester genetic amniocentesis were
incubated for 6 h at 378C and were cultured on media speciﬁc for group B streptococcus (GBS) and E. coli.
Concurrently, samples were analyzed with real-time ﬂuorescent PCR (Roche LightCycler) using DNA primers
and probes designed to detect the CAMP factor encoding cfb gene and uidA gene of GBS and E. coli,
respectively. For positive control and to simulate amniotic ﬂuid colonization, 104 cfu/ml of GBS and E. coli were
inoculated on sterile amniotic ﬂuid and incubated for 6 h. Bacterial genomic DNA for the two organisms was
extracted and puriﬁed via the two-step precipitation method using a commercial kit. The real-time PCR assays
were also tested against 25 non-GBS and non-E. coli bacterial species. The lower limit of detection for each
pathogen was established using serial dilution of bacterial genomic DNA.
Results: All patient samples were negative for evidence of GBS and E. coli with both culture and real-time PCR
methods. Amniotic ﬂuid samples inoculated with GBS and E. coli were positive with real-time PCR whereas the
25 bacterial species other than GBS or E. coli tested negative with the assay. Average total sample processing
time including the pre-enrichment step was 7 h 40 min. The average cost for DNA extraction and PCR testing
was $8.50 per test.
Conclusion: Real-time ﬂuorescent PCR is a valid and reliable method for detection of speciﬁc pathogens in
amniotic ﬂuid. This technique is sensitive for low inoculation levels. Real-time ﬂuorescent PCR has potential to
impact clinical management as a rapid, reliable detection method for GBS and E. coli in chorioamnionitis.
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INTRODUCTION
Preterm birth occurs in approximately 11% of all
pregnancies. Preterm labor may be initiated by
infection in 33% of cases with intact membranes
and in 40% with preterm premature rupture of
membranes (pPROM). Early preterm birth (532
weeks gestation) has the strongest association with
infection
1. Neonatal sepsis occurs more com-
monly with early preterm birth, accounting for a
large portion of perinatal morbidity and mortality.
Pathogens that have been isolated from amniotic
ﬂuid in these cases include Ureaplasm urealyticum,
Mycoplasm hominis, fusobacterium species, prevo-
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lactiae, anaerobic streptococci and Escherichia
coli
2,3. In the pathogenesis of intra-amniotic
infection, or chorioamnionitis, it appears that
vaginal organisms overcome available cervical
barrier and immunity factors and penetrate the
chorioamnion to enter the amniotic ﬂuid.
Ultimately, some fetuses become infected
4.
Identifying the gravid patient destined to
deliver prematurely because of ascending genital
tract infection is difﬁcult. Many patients remain
asymptomatic until they present in preterm labor,
and most of them do not show signs of
chorioamnionitis. Even patients with pPROM
often lack clinical evidence of infection upon
presentation. Current clinical management of
preterm labor and pPROM does not universally
include routine amniocentesis because there are
no rapid, reliable diagnostic tests for intra-
amniotic infection and because infection rates
vary among clinical populations. Amniotic ﬂuid
culture takes 48 to 72 h, and may lack the
sensitivity needed to reliably identify infection at
a stage when intervention could alter outcome.
Amniotic ﬂuid glucose, Gram stain and leukocyte
esterase assays provide rapid results, but have poor
predictive value for infection-mediated preterm
labor, and even less for identifying the neonate
destined to develop sepsis. Ideally, accurate
identiﬁcation of bacterial invasion of the amniotic
cavity might allow expedient and targeted man-
agement of infection-mediated preterm labor.
PCR is used to identify genetic material of
pathogenic microorganisms by ampliﬁcation,
with highly speciﬁc and sensitive results, and has
been shown to detect bacteria in amniotic ﬂuid at
a higher rate than standard microbial cultures
3,5,6.
Unfortunately, PCR requires additional labora-
tory techniques to detect the ampliﬁed genomic
signal, taking up to 1 day to obtain results. Real-
time PCR employs the same biomolecular
techniques that provide the sensitivity and
speciﬁcity of traditional PCR, but detection of
the pathogenic microorganism occurs during the
ampliﬁcation process, shortening the time to
detection of pathogen.
The objective of our study was to develop a
valid, reliable test for detection of GBS and E. coli
in amniotic ﬂuid.
MATERIALS AND METHODS
This study was initiated after approval by the
Institutional Review Board at David Grant
USAF Medical Center. For genetic analysis,
40 amniotic ﬂuid samples were obtained from
women undergoing mid-trimester amniocent-
esis. To test amniotic ﬂuid samples for GBS and
E.coli infection by standard culture and con-
ventional and real-time PCR, 2 ml of each
sample were incubated for 6 h at 37 C. Samples
were frozen, stored at –70 C and batched for
later analysis. An aliquot of each sample was
cultured according to CDC recommendations
for detection of GBS and E.coli. A second
aliquot was processed for traditional and real-
time ﬂuorescent PCR using a Roche Light-
Cycler. Bacterial DNA was extracted using the
Gentra Systems Puregene DNA isolation kit,
modiﬁed by the addition of a second precipita-
tion step.
Pathogen genomic targets
The real-time PCR probe for GBS targeted the
cfb gene encoding the Christie-Atkins-Munch-
Petersen (CAMP) factor
7. Hybridization probes
designed to anneal to an internal sequence of the
153 base pair (bp) amplicon were used. The E. coli
target for the assay consists of a 186 bp sequence
of the uidA gene encoding the b-glucoronidase
protein. GBS or E. coli was detected in each
sample in triplicate using the Hybridization (GBS)
or Taqman (E.coli) probe systems in the Light-
Cycler.
Speciﬁcity of assays
To assess the speciﬁcity of the Hybridization and
Taqman probe assays, a battery of 25 non-GBS
and non-E coli bacterial strains were grown on
blood agar plates, and 40 ml of a 104 cfu/ml
bacterial suspension of each strain were added to
500 ml amniotic ﬂuid sample and incubated for
6 h at 37 C. The sample was then tested for the
presence of GBS and E coli target DNA on the
LightCycler, in duplicate.
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Streptococcus agalactiae (ATCC 12386) and E. coli
(ATCC 35218) were grown in pure culture on
blood agar plates and diluted to 104 cfu/ml. Then
40 ml (25 cfu total) of each of the bacterial
suspensions were added to 500 ??mu?l aliquots of
amniotic ﬂuid, incubated at 37 C for 6 h and
stored at –80 C until analyzed. PCR-grade
distilled, de-ionized water was used as negative
control for both traditional PCR and real-time
PCR. The dilute bacterial suspensions served as
the positive control for traditional and real-time
PCR.
Limit of detection
To determine the lower limit of detection of the
assays, pure genomic DNA extracted from GBS
or E. coli cultured on sheep blood agar was
obtained using the Gentra Puregene Isolation kit
with the modiﬁcation noted above. RNAse and
proteinase K treatment steps after DNA isolation
were added to remove contaminating proteins
and RNA. The concentration of DNA was
calculated by measuring absorbance at 260 and
280 nm. DNA concentration was adjusted to
1 mM and serial dilution of DNA in Tris buffer
was performed. GBS or E. coli was detected from
each concentration in triplicate using the Hybri-
dization (GBS) or Taqman (E. coli) probe systems
in the LightCycler.
RESULTS
As was anticipated on the basis of the clinical
histories, none of the 40 native amniotic ﬂuid
samples had evidence of E.coli or GBS by culture,
conventional PCR or real-time PCR. All
amniotic ﬂuid samples inoculated with GBS or
E. coli were uniformly positive by real-time PCR
(Figure 1). PCR product results were conﬁrmed
by gel electrophoresis (Figure 2). Therefore, in
our laboratory the real-time PCR system was
100% sensitive and speciﬁc for detecting GBS and
E. coli in amniotic ﬂuid. In the limit of detection
studies we were able to consistently detect 25
genomic copies (50 cfu/ml) (Figure 3). The
average time to complete the real-time PCR
testing was 1 h 40 min after the 6-h incubation
period study protocol had elapsed.
DISCUSSION
We have shown that real-time PCR is a sensitive
(100%) and rapid method for detecting pathogens
in amniotic ﬂuid that are commonly involved in
the pathogenesis of preterm labor and adverse
neonatal outcome. We consistently detected
artiﬁcially created infected amniotic ﬂuid samples
and consistently detected greater than 50 cfu/ml
of pathogen. We also proved that the real-time
PCR system is highly speciﬁc (100%), by showing
that the probes tested did not detect alternative
bacterial species or produce false-positive results
in control samples devoid of bacteria. Real-time
PCR proved to be valid and reliable when
Figure 1 LightCycler
TM PCR graph showing hybridiza-
tion probe (GBS) and Taqman (E. coli) results,
demonstrating (A) increased ﬂuorescence for group B
streptococci(solid)positivecontrols(dash),and(B)E.coli
(solid) positive controls (dash). No ﬂuorescence was
observed for the negative control (PCR grade water) and
patients’ samples negative for GBS or E. coli (broken line)
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PCR. The overall time required to obtain results
from real-time PCR was 7 h 40 min, including
the incubation time. Testing was completed at a
material cost of $8.50 per amniotic ﬂuid sample.
We have also shown with sensitive and speciﬁc
biomolecular techniques that the amniotic cavity
under uncomplicated clinical conditions is sterile
with respect to GBS and E. coli in the mid-
trimester.
If conﬁrmed in future studies, the clinical
implications of our data may lead to changes in
diagnostic methods and clinical management of
chorioamnionitis, preterm labor and pPROM.
Future research should focus on validating this
real-time PCR system in other clinical popula-
tions, including cases of suspected preterm labor,
pPROM or chorioamnionitis. We are currently
planning such a study, to include patients with
these diagnoses. We also plan to correlate PCR
results with various adverse neonatal outcomes.
With further study, it may become possible to
more accurately and more rapidly identify earlier
in gestation those pregnancies destined to deliver
premature neonates that may develop sepsis. Early
discovery of intra-amniotic infection may allow
speciﬁc therapy in utero and maintainance of such
pregnancies closer to term, as in the case of
listeriosis. Conversely, early identiﬁcation of
intra-amniotic bacterial invasion may indicate
expeditious delivery rather than ineffective ma-
ternal tocolytic or antibiotic therapy as the best
strategy for reducing neonatal infectious morbidity
and mortality.
Figure 2 Results of real-time PCR were conﬁrmed with agarose gel electrophoresis of PCR products. No
ampliﬁcation was observed for (A) GBS negative samples (A lanes 2–15 and 17) or (B) E. coli negative samples (B lanes
2–15 and 20–21). Negative control (PCR water, A18 and B19) tested appropriately. Positive control and spiked
sample for GBS (A19–20) yielded the 153 bp ampliﬁcation product whereas positive control and spiked sample for E.
coli (B17–18) yielded the 186 bp PCR product
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real-time PCR technology is a promising method
that may improve diagnostic accuracy and rapidity
in identifying intra-amniotic infection, and may
open new windows for applying therapy to
prevent preterm delivery and neonatal morbidity
and mortality from prematurity. However, before
this technique can be applied clinically, further
research is necessary. The sensitivity and speciﬁ-
city of real-time PCR needs to be evaluated and
validated in the most important clinical target
population, namely women at 24 to 32 weeks of
gestation who are at increased risk for preterm
delivery or pPROM or are suspected to have
preterm labor. In addition, probes for other
common and uncommon pathogens need to be
tested.
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